G-BA source · retrieved 2026-08-05
Structured conclusion
1 source-verified result
Patient group
Erwachsene mit symptomatischer hypertropher obstruktiver Kardiomyopathie (NYHA Klasse II–III)
Hint of considerable added benefit
Comparator
- Therapie nach ärztlicher Maßgabe unter Berücksichtigung von nicht-vasodilatierenden Betablockern, Verapamil und Diltiazem
Decision orientation
4 cited claims
Each claim links to the official G-BA page or an exact PDF page range.
Official metadata
Case context
Listed normative targets
A listed target is not treated as a new directive version unless an official version source exists.
Official document package